Risk of cardiac arrhythmias after electrical accident: a single-center study of 480 patients - Pilecky D, Vamos M, Bogyi P, Muk B, Stauder D, Racz H, Nyolczas N, Duray GZ, Zacher G, Zima E.
OBJECTIVE: Patients with electrical injury are considered to be at high risk of cardiac arrhythmias. Due to the small number of studies, there is no widely accepted guideline regarding the risk assessment and management of arrhythmic complications after el... (Source: SafetyLit)
Source: SafetyLit - February 18, 2019 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news
These medtech companies raised the most VC in 2018
[Image from unsplash.com]Venture capital firms invested more than $2.9 billion in medical device companies in 2018 — a slight increase from the $2.8 billion raised in 2017, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights. Both the first and second quarters of 2018 saw an increase in investments, totaling nearly $778 million and $786 million respectively. The third and fourth quarters were slightly lower, with medtech companies raising $738 million in Q3 and nearly $641 million in Q4. There were 218 deals in 2018, a slight decrease from the 229 deals involving me...
Source: Mass Device - February 15, 2019 Category: Medical Devices Authors: Danielle Kirsh Tags: Business/Financial News venture capital Source Type: news
Syncope Monitoring in ED: 2 Hours Okay for Low-Risk Patients Syncope Monitoring in ED: 2 Hours Okay for Low-Risk Patients
Patients with syncope who present to the emergency department and who are at low risk for serious arrhythmia can be discharged home after 2 hours of electrocardiogram monitoring, new data show.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 13, 2019 Category: Cardiology Tags: Emergency Medicine News Source Type: news
RSA reactivity in response to viewing bullying film and adolescent social adjustment - Cui L, Zhang X, Houltberg BJ, Criss MM, Morris AS.
This study assessed adolescent respiratory sinus arrhythmia (RSA) reactivity while watching a bullying film clip from Boyz'n the Hood. We emphasized the importance of considering measurement context of RSA and examined whether RSA reactivity moderated the ... (Source: SafetyLit)
Source: SafetyLit - February 13, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Underutilized cardiac MRI stress test predicts mortality
A stress test with cardiac MRI can do more than simply assess heart function....Read more on AuntMinnie.comRelated Reading: SPECT, MRI together advance arrhythmia treatment Imaging modalities differ in assessing key heart metric New protocol enables faster, cheaper cardiac MRI scans Cardiac MRI offers prognosis for hard-to-find infarctions MRI technique could let cardiac patients breathe easier (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2019 Category: Radiology Source Type: news
Acutus ‘Uncovers’ AcQMap’s Effectiveness with Trial Data
Data from the UNCOVER-AF trial reinforces the effectiveness of Acutus Medicalâs AcQMap Imaging System in persistent atrial fibrillation (AF) ablation procedures. The Carlsbad, CA-based company released the data in late January at the 24th annual AF Symposium in Boston. AcQMap is a technology that combines charge mapping and high-resolution ultrasound imaging to create animated, 3D images in seconds that display anatomy and atrial arrhythmias. In the UNCOVER AF trial, investigators used AcQMap and a variety of on-market ablation technologies, to treat a total of 127 patients with de novo, persistent AF at...
Source: MDDI - February 6, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Imaging Source Type: news
J & J ’ s Biosense Webster launches IDE-cleared Qdot Micro RF ablation trial
Johnson & Johnson‘s (NYSE:JNJ) Biosense Webster said yesterday it launched a new FDA investigational device exemption study of its Qdot Micro radiofrequency ablation catheter exploring its use in treating symptomatic drug-refractory paroxysmal atrial fibrillation. The first patient in the trial has already been treated, with the procedure taking place at NYU Langone Health’s Heart Rhythm Center, the Irvine, Calif.-based J&J division said. “The delivery of 90 watts of RF power in a short, four-second ablation session is a significant advancement in the treatment of paroxysmal atrial fibri...
Source: Mass Device - February 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Food & Drug Administration (FDA) johnsonandjohnson Source Type: news
SPECT, MRI together advance arrhythmia treatment
The combination of information from cardiac MRI and iodine-123 metaiodobenzylguanidine...Read more on AuntMinnie.comRelated Reading: Augmented reality primed for MR-guided cardiac ablation 3D virtual heart helps pinpoint irregular heartbeat Imaging modalities differ in assessing key heart metric New protocol enables faster, cheaper cardiac MRI scans ASNC releases new guidelines for SPECT MPI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2019 Category: Radiology Source Type: news
Acutus Medical touts 12-month AcQMap-guided AF ablation trial data
Acutus Medical today released 12-month data from the Uncover-AF trial of its AcQMap cardiac imaging and mapping system exploring its use in persistent atrial fibrillation ablation procedures. Results from the trial were presented at the 24th Annual AF Symposium in Boston, the Carlsbad, Calif.-based company said. Acutus Medical’s AcQMap system is designed to detect and display standard voltage-based and higher resolution charge-source maps, and is able to generate real-time, 3D images of the heart chamber using ultrasound. “We have mapped arrhythmias with the same technology for decades without asking if th...
Source: Mass Device - January 29, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Acutus Medical Source Type: news
Myocardial infarction following a blunt chest trauma: a case report - Li X, Wang Z, Yang Y, Meng F, He Y, Yang P.
RATIONALE: Blunt cardiac injury (BCI) is a common complication after blunt chest trauma, which can lead to mild arrhythmia, severe chamber or valvular rupture, or even death. Myocardial infarction following blunt chest trauma is a rare but fatal condition.... (Source: SafetyLit)
Source: SafetyLit - January 29, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Study uncovers why heart attack triggers arrhythmia in some, explores potential treatment
(University of California - San Diego) A team of researchers led by the University of California San Diego has identified a genetic pathway that causes some individuals to develop an abnormal heart rhythm, or arrhythmia, after experiencing a heart attack. They have also identified a drug candidate that can block this pathway. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 28, 2019 Category: International Medicine & Public Health Source Type: news
Prolonged QT syndrome due to donepezil: a reversible cause of falls? - Jackson EG, Stowe S.
We report a case of prolonged QT syndrome caused by donepezil which resulted in a fall and hip fracture. In this case... (Source: SafetyLit)
Source: SafetyLit - January 21, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Alcohol and the Electric Atrium: How Drinking Promotes AF? Alcohol and the Electric Atrium: How Drinking Promotes AF?
Electrophysiologic studies are helping define the nature of atrial fibrillation's myocardial remodeling effects in moderate drinkers with the arrhythmia.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 18, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news
Lightning skin burns: a case report - Abdelraouf T, ElHafez M, Elmorsy E.
This study presents a report on a 50-y... (Source: SafetyLit)
Source: SafetyLit - January 15, 2019 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news
Not Just Acid Reflux: The Need to Think Worst First
A previously healthy, well-appearing 42-year-old female living in a modern, high-rise apartment in downtown Los Angeles calls 9-1-1 at 5:30 am complaining of worsening of a burning, epigastric pain she had been experiencing for the last three days. She reports associated nausea and non-bloody, non-bilious vomiting, and that she couldn’t manage to get comfortable in bed until she finally decided to call for help at daybreak. During her 9-1-1 call, she reports “pain, like heartburn, that just woke me up again and I had to throw up, … and then I was sweating so much.” Using the Los Angeles Tiered Disp...
Source: JEMS Special Topics - January 13, 2019 Category: Emergency Medicine Authors: Stephen Sanko, MD, FACEP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news
Machine Matches Docs for Arrhythmia Detection
(MedPage Today) -- Investigators said rare instances of VT misclassification were'very reasonable'(Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 9, 2019 Category: Cardiology Source Type: news
iRhythm Finds Its Groove at the Intersection of Cardiology and AI
iRhythm Technologies has the distinct feature of being at the intersection of some of the hottest markets in medtech â cardiology, wearables, and artificial intelligence. The San Francisco-based company has developed, the Zio Patch XT, a wearable technology to monitor heart rate activity for up to 14 days and is set to present at the 37th Annual J.P. Morgan Healthcare Conference this week. Tim King, iRhythmâs president and CEO spoke to MD+DI ahead of the companyâs presentation about the company's success and its goals going forward. âThe tool of choice...
Source: MDDI - January 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Digital Health Source Type: news
Stanford, iRhythm's deep neural network matches cardiologists at arrhythmia classification
An algorithm trained on a deep neural network was able to perform on par with board certified cardiologist when annotating 12 different types of hearth rhythms. (Source: mobihealthnews)
Source: mobihealthnews - January 6, 2019 Category: Information Technology Source Type: news
New Apple Watch OK'd for Arrhythmia Detection
(MedPage Today) -- Single-lead electrocardiogram built into latest version cleared by FDA (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 28, 2018 Category: American Health Source Type: news
New study shows link between secondhand smoke and cardiac arrhythmia
(University of California - Davis Health) Continuous indoor exposure to secondhand tobacco smoke triggers changes in the heart's electrical activity, known as cardiac alternans, that can predict cardiac arrhythmia and sudden cardiac death, a new study from UC Davis Health researchers shows. The authors believe the study, conducted in mice, suggests that secondhand smoke exposure alters cells that regulate how the heart beats. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 26, 2018 Category: International Medicine & Public Health Source Type: news
Medical News Today: Taquicardia: Causas, s íntomas y tratamientos
Descubra toda la informaci ón necesaria sobre los cinco tipos más comunes de taquicardia o frecuencia cardíaca más rápida de lo normal, la forma de prevenirla y las opciones para tratarla. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 19, 2018 Category: Consumer Health News Tags: Arrhythmia Source Type: news
Cardiva Medical wins FDA PMA for Vascade MVP vascular closure device
Cardiva Medical said today it won FDA premarket approval for its Vascade MVP venous vascular closure device. The Vascade MVP system is composed of a thrombogenic bioabsorbable collagen patch and a collapsible mesh disc, the Santa Clara, Calif.-based company said. The device functions by placing a collapsible mesh disc against the inner vessel wall to stop bleeding followed by a collagen patch and the removal of the mesh disc, the company said. The collagen patch is designed to expand, seal and stop bleeding and is later absorbed by the body. Cardiva touted the Vascade MVP as the first and only vascular closure system ...
Source: Mass Device - December 18, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Pre-Market Approval (PMA) Regulatory/Compliance Vascular Cardiva Medical Inc. Source Type: news
Researchers pioneer use of new method to treat life-threatening heart arrhythmias in dogs
(Morris Animal Foundation) Morris Animal Foundation-funded researchers have developed a new treatment for dogs with a rare, but life-threatening, arrhythmia caused by atrioventricular accessory pathways (APs). The minimally invasive technique, which uses radiofrequencies, is modified from a human cardiology procedure and has a more than 95 percent success rate in treating dogs with this type of arrhythmia. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 10, 2018 Category: International Medicine & Public Health Source Type: news
FFR for CABG; Botox Arrhythmia Prevention; Med Device Investigations
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 3, 2018 Category: Urology & Nephrology Source Type: news
J & J ’ s Biosense Webster launches Heliostar multi-electrode ablation cath trial
Johnson & Johnson‘s (NYSE:JNJ) Biosense Webster said this week that it enrolled and treated the first patient in its Stellar U.S. investigational device exemption study. The 640-patient trial is designed to assess the safety and efficacy of the Heliostar multi-electrode radiofrequency balloon ablation catheter as a treatment for drug refractory recurrent paroxysmal atrial fibrillation. The Heliostar device features 10 electrodes and is designed to allow electrophysiologists to achieve pulmonary vein isolation with a single application of RF energy, according to Biosense Webster. Cardiac electrophysiologists Drs. ...
Source: Mass Device - November 30, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Catheters Clinical Trials Featured Wall Street Beat Biosense Webster johnsonandjohnson Source Type: news
J & amp;J Subsidiary Launches IDE Study for AF
A new U.S. study aims to evaluate a radiofrequency (RF) balloon ablation catheter for the treatment of symptomatic drug refractoryÂ recurrent paroxysmal (intermittent) atrial fibrillation. Biosense Webster, a subsidiary of Johnson & Johnson, said the investigational device exemption study will enroll up to 640 patients at as many as 40 clinical sites worldwide. The STELLAR studyÂ will evaluate the company's HeliostarÂ RF balloon ablation catheter. "This new balloon catheter is unique because it conforms to any pulmonary vein anatomy and allows me to control electrodes individually ...
Source: MDDI - November 29, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
ECG Educational Standards for Prehospital Providers
Conclusion As the role of evidence-based medicine becomes more prominent in the field of emergency medicine, a clear view of the current state of ECG education and platform from which to implement uniform standards becomes increasingly essential; especially as research expands into the prehospital setting. Further research into EMS education may identify both strengths and weaknesses in basic ECG interpretation appropriate for first responders. Implementing minimum ECG interpretation standards for EMS personnel nationwide is one potential option to ensure prehospital educational institutions stay responsive to current scie...
Source: JEMS Special Topics - November 27, 2018 Category: Emergency Medicine Authors: Jonathan Barney, BA, EMT, MS3 Tags: Training Exclusive Articles Cardiac & Resuscitation Source Type: news
BioSig inks Pure EP first-in-human study deal with Texas Cardiac Arrhythmia Institute
BioSig Technologies (OTCQB: BSGM) said today that it inked a deal with Austin’s Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to launch first-in-human studies using its Pure EP system. The Santa Monica, Calif.-based company’s Pure EP system is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. The device is intended to reduce noise and artifacts to produce high-fidelity cardiac signals, which the company claims...
Source: Mass Device - November 27, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Clinical Trials BioSig Technologies Source Type: news
Arrhythmia after an Energy Drink: SVT?
ECG Challenge: A 32-year-old woman is brought by ambulance to the ED. She is having palpitations after consuming 2 energy drinks. What's your ECG read? (Source: ConsultantLive)
Source: ConsultantLive - November 26, 2018 Category: Internal Medicine Authors: Brady Pregerson, MD Tags: Cardiovascular Diseases Source Type: news
Abbott launches FlexAbility cath ventricular tachycardia ablation trial
Abbott (NYSE:ABT) said yesterday that it launched a study aiming to evaluate ablation treatments for patients with ventricular tachycardia, touting it as the first such trial of its kind. In the trial, dubbed the Less-VT study, investigators will explore the safety and effectiveness of ablation with the Chicago-area medtech giant’s FlexAbility ablation catheter in treating monomorphic ventricular tachycardia in patients who are unresponsive to drug therapy. “For some patients with sustained monomorphic ventricular tachycardia, drug therapy is an ineffective treatment option. We want to build a body of clin...
Source: Mass Device - November 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Featured Abbott Source Type: news
Abbott Initiates Study to Evaluate Ablation as a Frontline Treatment for Patient's Suffering from a Common but Complex Cardiac Arrhythmia
LESS-VT Study is the first U.S. clinical trial to evaluate the safety and effectiveness of ablation treatment for patients with monomorphic ventricular tachycardia, a common heart rhythm disorder (Source: Abbott.com)
Source: Abbott.com - November 20, 2018 Category: Pharmaceuticals Source Type: news
What is sick sinus syndrome?
Sick sinus syndrome ? also known as sinus node disease or sinus node dysfunction ? is a group of heart rhythm problems (arrhythmias) in which the heart's natural pacemaker (sinus node) doesn't work properly. The sinus node is an area of specialized cells in the upper right chamber of the heart that controls the rhythm [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 20, 2018 Category: Databases & Libraries Source Type: news
The association between unexplained falls and cardiac arrhythmias: a scoping literature review - Wiseman T, Betihavas V.
BACKGROUND: Falls in older adults are common. Age is a risk factor for falls and with an ageing population, presentation to the emergency department (ED) resulting from falls is rising. Reasons for falls in older adults are numerous and include cardiac arr... (Source: SafetyLit)
Source: SafetyLit - November 16, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
ENCORE-VT: Noninvasive Ablation of VT Could Disrupt EP ENCORE-VT: Noninvasive Ablation of VT Could Disrupt EP
A small study suggests that ventricular arrhythmia may be treated without the need for catheters and anesthesia. John Mandrola, MD, is impressed with the findings and the investigators'lack of hyperbole.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2018 Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news
Firefighting and On-Duty Cardiac Deaths
Conclusion Using autopsy data from on-duty fatalities that occurred over a 15-year period, the underlying cardiac pathological conditions associated with sudden cardiac death were investigated among firefighters. Our data suggest a need for updated and improved medical screening for firefighters. Particularly, screening for CHD and cardiac enlargement should be incorporated into a firefighter’s routine screening. Given the important role of EMS in ensuring both civilian and firefighter safety, EMS personnel should be alert to the potential to encounter either sudden cardiac arrest or a myocardial infarction in firefi...
Source: JEMS Special Topics - November 12, 2018 Category: Emergency Medicine Authors: Denise L. Smith, PhD, FACSM Tags: Training Exclusive Articles Source Type: news
Cardiva touts results from pivotal Vascade MVP vascular closure device trial
Cardiva Medical today released results from the pivotal study of its Vascade MVP vascular closure device intended for multi-access venous closure following electrophysiology procedures, touting that the trial met its primary and secondary endpoints. The results from the AMBULATE trial were presented today at the American Heart Association’s annual Scientific Sessions by Texas Cardiac Arrhythmia Institute exec medical director Dr. Andrea Natale. The Vascade system is composed of a thrombogenic bioabsorbable collagen patch and a collapsible mesh disc, the Santa Clara, Calif.-based company said. The device fun...
Source: Mass Device - November 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Vascular Cardiva Medical Inc. Source Type: news
Cardiva Medical Has Strong Showing at AHA
Cardiva Medicalâs vascular closure system has met its clinical endpoints in the AMBULATE randomized pivotal trial. The Santa Clara, CA-based companyâs VASCADE MVP, a vascular closure system designed specifically for multi-access venous closure following electrophysiology procedures such as arrhythmia ablation was evaluated in the study. Results from the trial were presented at American Heart Association 2018 Scientific Sessions, held in Chicago. AMBULATE enrolled 204 patients who underwent arrhythmia ablation procedures by 28 physicians at 13 sites across the US. The treatment group had ...
Source: MDDI - November 9, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news
Medical News Today: How does a doctor diagnose atrial fibrillation?
Atrial fibrillation creates an irregular heart rhythm called arrhythmia. A doctor can use physical examination and machine testing to diagnose and treat this common heart disorder. Read on to learn more. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 9, 2018 Category: Consumer Health News Tags: Heart Disease Source Type: news
Some MI risk factors more hazardous to women than to men
Diabetes, smoking and hypertension more strongly associated with MI in women than in men Related items fromOnMedica Wait and hip measurement better indicator of heart attack risk than obesity Death rate higher in women after discharge for heart arrhythmias Women more likely to survive heart attack if treated by female doctor Raised risk of MI and mortality when starting sulfonylurea (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 8, 2018 Category: UK Health Source Type: news
CardioMech taps medtech vet Nehm for CEO | Personnel Moves, November 5, 2018
CardioMech taps medtech veteran Nehm for CEO Swedish mitral valve repair company CardioMech said today that it named medical device industry veteran Richard Nehm as president & CEO effective immediately. Nehm’s resume includes stints at Boston Scientific (NYSE:BSX), Abbott (NYSE:ABT) acquisition Tendyne and ATS Medical (acquired by Medtronic (NYSE:MDT)). CardioMech also named Spinal Stabilization Technologies president & CEO Mark Novotny as chairman. “There are more than 400,000 patients around the world that suffer from a leaky mitral valve due to prolapse or flail that are at a high-risk fo...
Source: Mass Device - November 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Business/Financial News Cantel Medical Corp. CardioMech Eos Imaging intersectent Medibio micronsolutions Personnel Moves Restoration Robotics Inc. Stereotaxis SurModics Inc. Vascular Insights Source Type: news
Preventing sudden cardiac death with genome editing
(Baylor College of Medicine) Gene editing successfully prevented sudden cardiac death in a mouse model of inherited cardiac arrhythmia disorder. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 30, 2018 Category: Biology Source Type: news
Ditch the Machine to Improve Accuracy in Blood Pressure Measurement and Diagnostics
Conclusion For the patient in this case, the decision to forego the convenience of a machine in favor of the skills of a knowledgeable paramedic was lifesaving. Much like the comparison often drawn between the old-fashioned barbell and more sophisticated exercise machines, newer, more complex, and more expensive might make a process more comfortable, but doesn’t always equate to superior results. As we surrender more and more of our hands-on skills to the ease of automated technology, we risk more than the loss of the aptitudes that form the foundation of sound patient assessment—we place our patients in jeopar...
Source: JEMS Special Topics - October 24, 2018 Category: Emergency Medicine Authors: Mark Rock, NRP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news
FDA approves Abbott ’ s HeartMate 3 as a destination therapy
Abbott (NYSE:ABT) said today it won FDA approval for its HeartMate 3 left ventricular assist device, now approved as a destination therapy for patients with advanced heart failure. With the approval, the Chicago-based company said that the device can now be used in patients not eligible for a transplant as a life-long implant. “We partner with physicians to holistically develop therapies that benefit patients and achieve better outcomes. The unique design of the HeartMate 3 LVAD—with its Full MagLev technology—takes an established innovation and improves upon it in meaningful ways to help people with...
Source: Mass Device - October 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Abbott Source Type: news
Study Highlights Surgery Benefits of P/D over EPP for Mesothelioma
This study focused on 30-day mortality and postoperative complications. It included a meta-analysis of 39 previous studies from 1990 to 2017, along with the New York Statewide Planning and Research Cooperative System database from 1995 to 2012. Study results included: 30 Day Mortality: EPP 5 percent; P/D 2 percent Postoperative Complications: EPP 46 percent; P/D 24 percent Postoperative Arrhythmias: EPP 20 percent; P/D 5 percent. Although there is no cure for pleural mesothelioma, aggressive surgery — with either the P/D or EPP — has been proven to extend survival times. According to a recent study pub...
Source: Asbestos and Mesothelioma News - October 19, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news
With Loop Recorder, Many Could Skip ICD for Inherited Arrhythmia
(MedPage Today) -- Devices get patients the right event adjudication, per single-center analysis (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - October 15, 2018 Category: Surgery Source Type: news
Variabilities in the Use of IV Epinephrine in the Management of Cardiac Arrest Patients
Discussion The results show a lack of standardization in epinephrine dosing across large EMS systems around the world, in spite of the existence of standard guidelines such as the 2015 AHA CPR and ECC Guidelines.5 Dosing maximums, epinephrine drip use, dosing amount and frequency, and dosing distinction for rhythms not being more consistent across the board shows the current state of uncertainty that epinephrine administration is in at this time. The AHA ECC Guidelines don’t specify dosing maximums or about distinguish between v fib and other rhythms.5 In those two categories, responding agencies showed a lack of sta...
Source: JEMS Special Topics - October 15, 2018 Category: Emergency Medicine Authors: Nidhish Lokesh, NREMT Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news
Respiratory sinus arrhythmia mediates links between borderline personality disorder symptoms and both aggressive and violent behavior - Thomson ND, Beauchaine TP.
Although emotion dysregulation (ED) is a core symptom of borderline personality disorder (BPD), tests of associations between ED and aggression and violence-which are common to BPD-are sparse. The authors evaluated mediating effects of an autonomic vulnera... (Source: SafetyLit)
Source: SafetyLit - October 15, 2018 Category: International Medicine & Public Health Tags: Violence and Weapons Issues Source Type: news
Cardialen Closes $17M Series B
Cardialen closed a $17 million Series B investment led by RiverVest Venture Partners, along with Qiming Venture Partners, HBM Healthcare Investments and Cultivation Capital. The Minneapolis-based company said it is developing the Cardialen unpinning termination (UPT) therapy, which delivers a sequence of low-energy electrical pulses designed to restore abnormally rapid heart rates to a normal rhythm. This low-energy therapy is intended to mitigate the negative effects of current high-energy defibrillators by delivering a much more tolerable, less debilitating treatment for patients with heart arrhythmias. â...
Source: MDDI - October 11, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news
NYT Report: Apple Watch ‘ should not be considered a medical device ’
The new electrocardiogram-equipped Apple (NSDQ:AAPL) Watch should not be considered a medical device, according to a new report from the New York Times. The article, written by Indiana University School of Medicine pediatrics professor Aaron Carroll, calls into question the downsides of the newly released device and the potential for both false positives and false negatives. Carroll acknowledged the possible positives of the device, including the ability for physicians to monitor patients from a distance and diagnosing heart problems in individuals that would possibly go undetected, but said that “just because s...
Source: Mass Device - October 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics mHealth (Mobile Health) Apple Source Type: news
Pins and needles: How acupuncture can help soothe an irregular heartbeat
(Natural News) Cardiac arrhythmia describes an irregular heartbeat caused by an interruption of electrical impulses in heart function. This group of conditions can be further broken down into bradycardia (slow heartbeat), tachycardia (fast heartbeat), flutter or fibrillation (irregular heartbeat), or premature contraction (early heartbeat). While most types of heart arrhythmia are relatively harmless (caused by... (Source: NaturalNews.com)
Source: NaturalNews.com - October 6, 2018 Category: Consumer Health News Source Type: news